Skip to main content
. 2022 Aug 3;10:946439. doi: 10.3389/fpubh.2022.946439

Table 4.

Risks for fetal CHDs in different titanium in pregnant women blood concentrations.

Group Levels Cases Controls cOR (95% CI) aOR (95% CI)
All CHDs Low 51 151 Reference Reference
High 46 43 2.731 (1.589–4.694) 2.706 (1.547–4.734)
The isolated CHDs Low 23 151 Reference Reference
High 20 43 1.820 (0.915–3.619) 1.976 (0.975–4.006)
The multiple CHDs Low 24 151 Reference Reference
High 24 43 2.640 (1.384–5.035) 2.382 (1.219–4.655)
The Syndrome CHDs Low 4 151 Reference Reference
High 2 43 0.777 (0.133–4.529) 0.829 (0.125–5.486)
PDA Low 36 151 Reference Reference
High 34 43 2.512 (1.416–4.455) 2.412 (1.336–4.357)
ASDs Low 24 151 Reference Reference
High 24 43 2.477 (1.297–4.730) 2.367 (1.215–4.609)
VSDs Low 3 151 Reference Reference
High 4 43 2.165 (0.454–10.334) 3.430 (0.578–20.354)
AVSDs Low 2 151 Reference Reference
High 2 43 1.908 (0.251–14.497) 1.462 (0.188–11.372)

aOR, adjusted odds ratio; cOR, crude odds ratio. Logistic regression was used to calculate odds ratios and 95% CIs; The optimal cut-off value of ROC curve of serum titanium concentration in pregnant women was divided into high and low concentrations; all models were adjusted for maternal pre-pregnancy BMI, maternal age, education, monthly household income, active/passive smoking during pregnancy (yes, no), alcohol consumption before pregnancy, take vitamins or minerals.